Omnitrust Wealth Management’s Boston Scientific BSX Stock Holding History

Omnitrust Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$217K	Buy	+3,454	New	+$276K	0.28%	55

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Omnitrust Wealth Management's BSX Position: Q1 2026 in Review

Omnitrust Wealth Management opened a new position in Boston Scientific (BSX) in Q1 2026: 3,454 shares worth $217K. The stake represents 0.28% of the portfolio and ranks #55 among its holdings.

1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Omnitrust Wealth Management held 3,454 shares of Boston Scientific worth $217K as of Q1 2026.
Boston Scientific was a new Omnitrust Wealth Management position in Q1 2026.
Boston Scientific made up 0.28% of Omnitrust Wealth Management's portfolio in Q1 2026, its #55 holding.
1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Omnitrust Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.